Form 4 for CYTK CYTOKINETICS INC
Accepted 2025-12-23 00:00:00 ET · period of report 2025-12-22 · accession 0001061983-25-000051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-23 | 2025-12-22 | CYTK | WIERENGA WENDELL | Dir | S - Sale+OE | $66.14 | -20.0K | 32.4K | -38% | -$1.32M |
| D | 2025-12-23 | 2025-12-22 | CYTK | WIERENGA WENDELL | Dir | M - OptEx | $7.61 | +20.0K | 52.4K | +62% | +$152.2K |
| D | 2025-12-23 | 2025-12-22 | CYTK | WIERENGA WENDELL | Dir | M - OptEx | $0.00 | -20.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-22 | S | D | 20,000 | $66.14 | 32,444 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-22 | M | A | 20,000 | $7.61 | 52,444 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2025-12-22 | M | D | 20,000 | $0.00 | 0 | D | $7.61 · 2016-06-18 to 2026-05-18 | 20,000 Common Stock |